EML4 and non-small cell lung carcinoma: These findings were supported by another study evaluating 134 surgically resected NSCLC specimens which found PD-L1 expression by immunohistochemistry to be higher in the cell lines positive for EML4-ALK compared to those negative for the fusion gene.